Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 2 (8) , 696-703
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminary safety resultsSeminars in Oncology, 2001
- Wide variations in the testing of lactose tolerance: results of a questionnaire study in Finnish health care centresScandinavian Journal of Clinical and Laboratory Investigation, 2000
- Changes in Intestinal Absorption of 5‐Fluorouracil‐Treated RatsBasic & Clinical Pharmacology & Toxicology, 1999
- Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancerEuropean Journal of Cancer, 1999
- LactobacillusGG—a human probiotic strain with thorough clinical documentationFood Reviews International, 1997
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- General Condition of Asymptomatic Patients with Advanced Colorectal Cancer Receiving Palliative Chemotherapy: A longitudinal studyActa Oncologica, 1992
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Survival after Postoperative Combination Treatment of Rectal CancerNew England Journal of Medicine, 1986
- Cancer chemotherapy-induced lactose malabsorption in childrenCancer, 1982